Bangalore: AstraZeneca Pharma India Ltd announced a change in its leadership with the appointment of Dr Sanjeev Panchal as Country President and Managing Director with effect from the first of January 2023. Sanjeev has been with AstraZeneca for 19 years.
Sanjeev is currently the Country President for AstraZeneca Malaysia. He played a critical role in supporting the government in combating the pandemic through AstraZeneca’s Covid-19 vaccine and long-acting monoclonal antibodies, as well as leading the corporate affairs strategy and sustainability initiatives.
Commenting on his appointment, Dr Sanjeev Panchal said, “I am delighted to return to India and take on the journey that Gagandeep Singh has established for the country, and I am really looking forward to collaborating with the team as we continue to push the boundaries of science to make health happen for people, society and planet.”
Expressing his delight in onboarding Dr Panchal, Gagandeep Singh, Country President, AstraZeneca Pharma India Ltd said, “I would like to congratulate the entire India team for achieving great feats in the past five years despite the pandemic. We are today poised to explore more areas to be able to extend benefits to more and more patients. I am very happy to see my fellow colleague and friend Sanjeev coming into this role and wish him all the best to capitalise on the opportunity ahead of us.”